More Globe Newswire

View Older Stories View Newer Stories

Oct 17, 2025 07:30AM StorageVault Finalizes and Receives Additional Expropriation Compensation, and Grows Third Party Management Platform
Oct 17, 2025 07:30AM PharmaCorp Rx Inc. Files Final Short Form Base Shelf Prospectus
Oct 17, 2025 07:30AM Prelude Therapeutics Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors
Oct 17, 2025 07:23AM Transaction in Own Shares
Oct 17, 2025 07:05AM 10th China International Copyright Expo & 2025 International Copyright Forum Held in Qingdao
Oct 17, 2025 07:05AM Issue of Equity - DRIS
Oct 17, 2025 07:05AM 10th China International Copyright Expo & 2025 International Copyright Forum Held in Qingdao
Oct 17, 2025 07:05AM Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
Oct 17, 2025 07:00AM Directors and Officers of Chicago Atlantic Real Estate Finance Purchase 54,000 Shares of Common Stock on the Open Market
Oct 17, 2025 07:00AM Guardian Capital Announces October 2025 Cash Distributions for Guardian Capital ETFs
Oct 17, 2025 07:00AM Emerita Extends El Cura Deposit 90 Meters Westward, Intersecting 4.1 Meters Grading 3.9% copper, 3.6% lead 8.5% Zinc, 4.08 g/t gold and 96.4 g/t silver
Oct 17, 2025 07:00AM Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare® Interventional Dry Eye Procedure
Oct 17, 2025 07:00AM CfPA Announces 2025 Regulated Investment Crowdfunding Summit: Shaping the Future of Capital Formation
Oct 17, 2025 07:00AM Tonix Pharmaceuticals Presented Data on TNX-801 Mpox Vaccine at World Vaccine Congress–Europe 2025
Oct 17, 2025 07:00AM Major Drilling Announces Normal Course Issuer Bid
Oct 17, 2025 07:00AM XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
Oct 17, 2025 07:00AM Rafael Nuissier Introduces “The Funnel Formula” and New Website to Empower Businesses With Predictable Growth Strategies
Oct 17, 2025 07:00AM Fabrinet Announces Retirement of Founder and Chairman Tom Mitchell After 25 Years of Visionary Leadership
Oct 17, 2025 07:00AM Tilray Brands Marks Seven Years of Cannabis Legalization in Canada with the #1 Market-Leading Position by Revenue and Pioneering Brands with Growing Market Share in the World’s Largest Federally Leg
Oct 17, 2025 07:00AM New Crypto Mutuum Finance (MUTM) Nears $20M in Funding With V1 Launch Scheduled for Q4 2025
Oct 17, 2025 07:00AM Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annu
Oct 17, 2025 07:00AM Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025
Oct 17, 2025 07:00AM Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease
Oct 17, 2025 06:58AM Chiesi Global Rare Diseases and Protalix Biotherapeutics Acknowledge CHMP Negative Opinion on Every Four Week Dosing Regimen of Elfabrio® (pegunigalsidase alfa) in the EU
Oct 17, 2025 06:55AM Genco Shipping & Trading Limited Announces Third Quarter 2025 Conference Call and Webcast
Oct 17, 2025 06:55AM Genco Shipping & Trading Limited Announces Third Quarter 2025 Conference Call and Webcast
Oct 17, 2025 06:55AM TransUnion Introduces New Mortgage Credit Offerings Leveraging Powerful Data – Delivering Lender Choice, Certainty and Homebuyer Savings
Oct 17, 2025 06:49AM Trusted No KYC Crypto-Friendly Casino of the Year
Oct 17, 2025 06:45AM CrossAmerica Partners to Announce Third Quarter 2025 Earnings Results on November 5
Oct 17, 2025 06:37AM Novartis Scemblix® receives positive CHMP opinion for the treatment of adults with newly diagnosed CML
Oct 17, 2025 06:36AM Form 8.3 - AXA INVESTMENT MANAGERS: JTC Plc
Oct 17, 2025 06:33AM iFLYTEK AINOTE 2 Launches: A Game-Changer for Professional Productivity
Oct 17, 2025 06:29AM Ensurge Micropower ASA - Registration of Share Capital Increase
Oct 17, 2025 06:30AM CHMP recommends EU approval of Roche’s Gazyva/Gazyvaro for lupus nephritis
Oct 17, 2025 06:29AM Jincheng Explores a New Model for Wellness Tourism Through Ancient Village Revitalization
Oct 17, 2025 06:17AM Publication of Circular and Notice of Meetings
Oct 17, 2025 06:09AM Form 8.5 (EPT/RI) - Greencore Group Plc
Oct 17, 2025 06:01AM AKVA group ASA: Status buyback of own shares
Oct 17, 2025 06:00AM Harvia Plc distributes a dividend of EUR 0.37 per share
Oct 17, 2025 06:00AM Mawson Infrastructure Group, Inc. Releases Preliminary Estimated Results for Third Quarter and Nine Months Ended September 30, 2025
Oct 17, 2025 06:00AM InStride Named to 2026 GSV 150
Oct 17, 2025 06:00AM Global Net Lease Upgraded to Investment Grade by Fitch Ratings
Oct 17, 2025 06:00AM Delta Defense Climbs to #25 on Wall Street Journal’s 2025 List of America’s Most Loved Workplaces
Oct 17, 2025 05:58AM 2025 Xiamen International Fashion Week grandly unfolds
Oct 17, 2025 05:55AM Form 8.3 - AXA INVESTMENT MANAGERS: Empiric Student Property Plc
Oct 17, 2025 05:30AM UCLOUDLINK Expands Global Reach of PetPhone to the Middle East in Partnership with AHAM AL TAFASIL
Oct 17, 2025 05:00AM Intention to Fundraise
Oct 17, 2025 05:00AM TOLREMO therapeutics Completes First In Human Dose Escalation for TT125-802 and Presents Solid Tumor Monotherapy Results at ESMO 2025
Oct 17, 2025 05:00AM ITM to Announce Phase 3 COMPETE Trial Post Hoc Subgroup Analyses and Host Satellite Symposium at NANETS 2025
Oct 17, 2025 05:00AM AKYNZEO® demonstrates superior prevention of chemotherapy-induced nausea and vomiting compared to the standard of care in patients receiving moderately emetogenic chemotherapy with additional predict
View Newer Stories View Older Stories